Market Cap

BioLineRx Ltd. Market Capitalization:

₪428.1 Million

ILS as of Jan. 1, 2024

US$118.5 Million

business BioLineRx Ltd. Company Profile

BioLineRx Ltd. Main Stock Listing

TASE: BLRX

Market Capitalization History of BioLineRx Ltd.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of BioLineRx Ltd. market cap

Date Market Cap YoY Change
Jan. 1, 2024 ₪428.1 M 188.14%
Jan. 1, 2023 ₪148.6 M -59.18%
Jan. 1, 2022 ₪364.0 M -32.88%
Jan. 1, 2021 ₪542.3 M 5.23%
Jan. 1, 2020 ₪515.4 M -75.44%
Jan. 1, 2019 ₪2.10 B -39.07%
Jan. 1, 2018 ₪3.44 B -2.96%
Jan. 1, 2017 ₪3.55 B -9.47%
Jan. 1, 2016 ₪3.92 B -42.87%
Jan. 1, 2015 ₪6.86 B -26.47%
Jan. 1, 2014 ₪9.33 B -41.84%
Jan. 1, 2013 ₪16.05 B 14.36%
Jan. 1, 2012 ₪14.03 B -48.25%
Jan. 1, 2011 ₪27.12 B -30.48%
Jan. 1, 2010 ₪39.00 B 174.51%
Jan. 1, 2009 ₪14.21 B -52.19%
Jan. 1, 2008 ₪29.72 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

BioLineRx Ltd. Categories

Israel languages Healthcare languages Biotechnology
Israel Healthcare Israel Biotechnology

Stocks & Indices

BioLineRx Ltd. has the following listings and related stock indices.


Stock: TASE: BLRX

Stock: NASDAQ: BLRX

Stock: FSX: YP2A

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.